AzTrials
AzTrials

FrailtyINEPPSNCT07379099

Implementation of the Personalized Care Plan (PCP) Proposed at the End of Step 2 of the ICOPE Program

An observational study of Frailty and Frailty at Older Adults, run by MSPU de Pins-Justaret at 1 site in France.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

The ICOPE (Integrated Care for the Elderly) program is based on an integrated approach including a personalized care plan (PCP). Negotiation methods with the patient and interprofessional cooperation could be key elements in the success of this program. Read more about this study

Who is it for?
Ages 60 years and older
Conditions the study is for
Frailty, Frailty at Older Adults
How many people
600 participants
Where
1 siteFrance
Study dates
1 Dec 2024to 1 Apr 2028
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 60 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Older adults aged 60 years and above, functionally independent

Who may be able to join

  • Age ≥ 60 years
  • ADL ≥ 5.5
  • Affiliated or beneficiary of a social security scheme or equivalent.
  • having completed a STEP 2 ICOPE
  • not opposed to the collection of their data

Who cannot join

None listed.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

France1 site, 1 recruiting
  • Maison de santé des Fontaines

    Toulouse, 31300

    Antoine Cabrol, Dr, 0033561499090, antoine.cabrol@dumg-toulouse.fr

    Recruiting

Other trials in France

About this study

Official title: Implementation of the Personalized Care Plan (PCP) Proposed at the End of Step 2 of the ICOPE Program : Description of the Procedures for Negotiating the PCP With the Patient, the Procedures for Implementing the PCP in a Multi-professional Setting, and Implementation of the PCP at 1 Year

The ICOPE (Integrated Care for the Elderly) program is based on an integrated approach including a personalized care plan (PCP). Negotiation methods with the patient and interprofessional cooperation could be key elements in the success of this program. The main objective is to evaluate the feasibility of the implementation of the ICOPE program on the number and content of the PCP carried out at 1 year

Medical subject headings
Frailty

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Proportion of PCP completed

    Proportion of personalized care plan (PCP) completed

    Measured: At 12 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted30 Jan 2026
  2. Study start1 Dec 2024
  3. Primary completion1 Jun 2027 (estimated)
  4. Study completion1 Apr 2028 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
600 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07379099
Sponsor's protocol ID
INEPPS
Acronym
INEPPS
Status last verified
Jan 2026
First submitted
23 Jan 2026
Last updated
30 Jan 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

An observational study of Frailty and Frailty at Older Adults, run by MSPU de Pins-Justaret at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 0 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 30 Jan 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Bruno Chicoulaa (0033661614449, bruno1.chicoulaa1@dumg-toulouse.fr), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Proportion of PCP completed (time frame: At 12 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 30 Jan 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in